Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Gene-editing startup incubated at Google goes public in $267M IPO

Verve Therapeutics, a cholesterol-targeting, gene-editing startup that's the first biotech to be incubated by the venture capital arm of Google, has hit the public market in a $267 million IPO — more than twice what it was originally hoping to raise.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.